Company intelligence
Tomorrow Access
Hands-on consulting bridging Japan and Silicon Valley.
About Tomorrow Access
Tomorrow Access is a Silicon Valley-based consulting firm bridging Japan and the US. Founded by Ken Sobajima — recognized in the Global Corporate Venturing (GCV) Top 50 Emerging Leaders out of 20,000+ CVC professionals worldwide — we bring 25+ years of business development experience, 20+ portfolio investments, and 30B+ JPY in business development track record. Our services: ・Business Strategy Consulting for Japanese enterprises expanding into the US ・Spot Consulting for time-sensitive market questions ・Startup Mentoring for Japanese founders entering Silicon Valley ・01 Expert Pitch — our flagship webinar series (30 sessions, 6,000+ participants) ・Trend Intelligence newsletter (3,000+ subscribers) We work hands-on with corporate innovation teams, CVCs, and startups to help them build their own path across borders.
Verified activity
Signals from Tomorrow Access
4 published signals
Capital & Finance
Tomorrow Access spent 96.6% of its revenue buying back its own stock.
Reported by Ken Sobajima
Capital & Finance
Tomorrow Access reported a net income for the latest nine months of positive figures, with a loss of $89.53 per share attributable to common stockholders.
Reported by Ken Sobajima
Legal & Regulatory
Tomorrow Access confirmed that Freenome acquired a new patent for a single stool sample test for colorectal cancer, which was granted U.S. FDA approval in July 2026, with the company holding the exclusive right to sell the test alone.
Reported by Ken Sobajima
Capital & Finance
Tomorrow Access filed an S-1 with the SEC on August 28, 2026, regarding Bamboo Insurance Services working in California homeowners insurance.
Reported by Ken Sobajima